Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma

被引:0
作者
Ding, Yan [1 ,3 ]
Zhao, Lei [1 ,3 ]
Zhang, Lijun [2 ,3 ]
Zhang, Xuanzhi [4 ]
Gu, Ting [2 ,3 ]
Zhang, Yanjin [2 ,3 ]
Bu, Liwen [1 ,3 ]
Zhang, Shuyi [1 ,3 ]
Luo, Jue [1 ,3 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Nursing Adm, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Crit Care, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200032, Peoples R China
关键词
Kidney clear cell carcinoma; Cuproptosis; Tumor microenvironment; Immunotherapy; Prognosis; CANCER; COPPER;
D O I
10.1007/s13193-024-02171-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cuproptosis is a novel form of cell death termed Cu-dependent cytotoxicity. However, the roles of cuproptosis-related genes (CPRGs) in Kidney Clear Cell Carcinoma (KIRC) have not been explored comprehensively. We obtained CPRGs and utilized consensus molecular clustering by "NMF" to stratify KIRC patients in the TCGA cohort. ssGSEA and CIBERSORT algorithms were used to evaluate the relative infiltration levels of immune cell types in a tumor microenvironment (TME). Risk_score based on CPRGs was calculated to predict patients' survival outcomes, and its performance was validated in the E-MTAB-1980 cohort. We identified three clusters with different clinicopathology characteristics. It was found that the cluster with the worst survival rates exhibited a higher enrichment of activated CD4/8+ T cells. In addition, we found the risk_score based on CPRGs could be used for patients' prognosis prediction, and its predictive value was successfully validated in the E-MTAB-1980 cohort. In this study, we uncovered the biological function of cuproptosis-related genes in the TME and its correlations with clinicopathological parameters and patients' prognosis in KIRC. These findings could provide new angles for immunotherapy of KIRC patients.
引用
收藏
页数:11
相关论文
共 23 条
[1]   Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer [J].
Aubert, Leo ;
Nandagopal, Neethi ;
Steinhart, Zachary ;
Lavoie, Genevieve ;
Nourreddine, Sami ;
Berman, Jacob ;
Saba-El-Leil, Marc K. ;
Papadopoli, David ;
Lin, Sichun ;
Hart, Traver ;
Macleod, Graham ;
Topisirovic, Ivan ;
Gaboury, Louis ;
Fahrni, Christoph J. ;
Schramek, Daniel ;
Meloche, Sylvain ;
Angers, Stephane ;
Roux, Philippe P. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[2]   Epidemiology of Renal Cell Carcinoma [J].
Capitanio, Umberto ;
Bensalah, Karim ;
Bex, Axel ;
Boorjian, Stephen A. ;
Bray, Freddie ;
Coleman, Jonathan ;
Gore, John L. ;
Sun, Maxine ;
Wood, Christopher ;
Russo, Paul .
EUROPEAN UROLOGY, 2019, 75 (01) :74-84
[3]  
Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12
[4]   Getting out what you put in: Copper in mitochondria and its impacts on human disease [J].
Cobine, Paul A. ;
Moore, Stanley A. ;
Leary, Scot C. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (01)
[5]   CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review [J].
Farhood, Bagher ;
Najafi, Masoud ;
Mortezaee, Keywan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) :8509-8521
[6]   Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma [J].
Giraldo, Nicolas A. ;
Becht, Etienne ;
Vano, Yann ;
Petitprez, Florent ;
Lacroix, Laetitia ;
Validire, Pierre ;
Sanchez-Salas, Rafael ;
Ingels, Alexandre ;
Oudard, Stephane ;
Moatti, Audrey ;
Buttard, Benedicte ;
Bourass, Sarah ;
Germain, Claire ;
Cathelineau, Xavier ;
Fridman, Wolf H. ;
Sautes-Fridman, Catherine .
CLINICAL CANCER RESEARCH, 2017, 23 (15) :4416-4428
[7]   GSVA: gene set variation analysis for microarray and RNA-Seq data [J].
Haenzelmann, Sonja ;
Castelo, Robert ;
Guinney, Justin .
BMC BIOINFORMATICS, 2013, 14
[8]   Renal cell carcinoma [J].
Jonasch, Eric ;
Gao, Jianjun ;
Rathmell, W. Kimryn .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[9]   Navigating metabolic pathways to enhance antitumour immunity and immunotherapy [J].
Li, Xiaoyun ;
Wenes, Mathias ;
Romero, Pedro ;
Huang, Stanley Ching-Cheng ;
Fendt, Sarah-Maria ;
Ho, Ping-Chih .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) :425-441
[10]   Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma [J].
Matsushita, Hirokazu ;
Sato, Yusuke ;
Karasaki, Takahiro ;
Nakagawa, Tohru ;
Kume, Haruki ;
Ogawa, Seishi ;
Homma, Yukio ;
Kakimi, Kazuhiro .
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (05) :463-471